PHOENIX -- For chronic or subacute subdural hematoma, embolization of the middle meningeal artery (MMA) reduced recurrence, three randomized trials showed. Two trials with the Onyx liquid embolic ...
The treatment of a subdural hematoma received a major boost with three new randomized controlled trials all showing large and significant benefits of a new embolization process done as an endovascular ...
The Onyx Liquid Embolic System (Medtronic) effectively occludes cerebral arteriovenous malformations (cAVMs), new observational data suggest. In a prospective, real-world study of more than 100 ...
Assistant Professor Jesse Jones, M.D., has been tapped by Medtronic to lead UAB in a clinical trial aimed at treating subdural hematomas. The study is titled “ Embolization of the Middle Meningeal ...
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx liquid embolic system demonstrates.
After a hit to the head or a fall, people, especially seniors, can develop a dangerous pooling of blood and fluid between the brain's surface and it's protective covering, the dura. These "subdural ...
(RTTNews) - Medtronic (MDT) has announced the enrollment of the first patient in its PELE (PEripheral Onyx Liquid Embolic) clinical trial, which will evaluate the safety and efficacy of the Onyx™ ...
Arsenal Medical announced that the FDA granted investigational device exemption approval for the RADIANT pivotal trial. The ...
A randomized, controlled study of a novel liquid embolic, NeoCast, adjunctive to surgeryWALTHAM, Mass.--(BUSINESS WIRE)--Arsenal Medical, a clinical-stage company developing innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results